The impact of renin-angiotensin-aldosterone system dysregulation: how aldosterone synthase inhibition could be a game changer

9 May 2026 (12:00 - 12:05)
Organised by: Logo
Congress Presentation Part of: New frontiers in cardiovascular medicine: SGLT2/aldosterone synthase inhibition in heart failure treatment and prevention Chronic Heart Failure Open Access Heart Failure 2026 Heart Failure Association (HFA)